Conversely, SGLT2 inhibitors might exert anti-inflammatory effect in animal models (Bonnet and Scheen, 2018), which could favorably impact the dysregulated process in the context of cytokine storm of COVID-19. This evidence concerns the gene SLC5A2 and COVID-19.